Intelligent bio solutions partners with cliantha research to conduct clinical study as part of fda 510(k) pathway

New york, feb. 28, 2024 (globe newswire) -- intelligent bio solutions inc. ("inbs" or the "company") (nasdaq: inbs), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its partnership with cliantha research, a full-service clinical research organization (cro), to perform a pharmacokinetic (pk) study forming part of the company's fda 510(k) clinical study plan.
INBS Ratings Summary
INBS Quant Ranking